Deals Shaping The Medical Industry, August 2022

In Vivo's Deal-Making column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in August 2022. Data provided by Biomedtracker.  

Dealmaking image, people on platform

Merck and Orna Therapeutics' deal to collaborate on RNA technology was the big pharma deal of August, and could be worth up to $3.5bn in total depending on whether Orna meets certain development, regulatory and sales milestones. (Also see "Merck Buys Into Orna's Circular RNA Platform With Emphasis On Vaccines" - Scrip, 16 August, 2022.)

In the medical device space, United Imaging Healthcare raised a hefty $1.6bn in its IPO and in diagnostics, Bio-Rad fully...

More from Deal-Making

More from In Vivo